Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing
Bimala Dhakal, Celine Man Ying Li, Runhao Li, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1043-1043
Open Access | Times Cited: 13

Showing 13 citing articles:

Landscape of human organoids: Ideal model in clinics and research
Xinxin Han, Chunhui Cai, Wei Deng, et al.
The Innovation (2024) Vol. 5, Iss. 3, pp. 100620-100620
Open Access | Times Cited: 32
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage
Yongjun Kou, Feng Geng, Deliang Guo
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1943-1943
Open Access | Times Cited: 57
Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions
Clara Musicco, Anna Signorile, Vito Pesce, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10420-10420
Open Access | Times Cited: 25
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment
Yoko Tabe, Marina Konopleva
Cancer Drug Resistance (2023) Vol. 6, Iss. 1, pp. 138-150
Open Access | Times Cited: 14
Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects
Bimala Dhakal, Yoko Tomita, Paul A. Drew, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3624-3624
Open Access | Times Cited: 14
International Union of Basic and Clinical Pharmacology: Fundamental Insights and Clinical Relevance Regarding the Carnitine Palmitoyltransferase Family of Enzymes
Rosalía Rodríguez‐Rodríguez, Miguel Baena, Sebastián Zagmutt, et al.
Pharmacological Reviews (2025), pp. 100051-100051
Open Access
Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: Current strategies and future challenges
Celine Man Ying Li, Runhao Li, Paul A. Drew, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102665-102665
Closed Access | Times Cited: 8
Study of the roles of cytochrome P450 (CYPs) in the metabolism and cytotoxicity of perhexiline
Zhen Ren, Si Chen, Xuan Qin, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 12, pp. 3219-3231
Open Access | Times Cited: 7
Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation
Bimala Dhakal, Celine Man Ying Li, Mahnaz Ramezanpour, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
In silicoinvestigation of the role of vitamins in cancer therapy through inhibition of MCM7 oncoprotein
Sunny Mukherjee, Sucharita Das, Navneeth Sriram, et al.
RSC Advances (2022) Vol. 12, Iss. 48, pp. 31004-31015
Open Access | Times Cited: 3
The Role of Fatty Acid Metabolism, the Related Potential Biomarkers, and Targeted Therapeutic Strategies in Gastrointestinal Cancers
Ruixi Xie, Ying Luo, Bowen Bao, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access
Fatty acid metabolism: A new target for nasopharyngeal carcinoma therapy
Juan Li, Pengbin Ping, Yanhua Li, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 6, pp. 652-668
Open Access
Page 1

Scroll to top